Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies

Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies

Clinical Trial Reimbursement in the U.S.: FAQs for MedTech CompaniesNicole Coustier
Published on: 19/03/2025

A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it.

Evidence PlanningFeatured
How Payer Claims Data Strengthens Medtech Value Stories: Examples from Peer-Reviewed Publications

How Payer Claims Data Strengthens Medtech Value Stories: Examples from Peer-Reviewed Publications

How Payer Claims Data Strengthens Medtech Value Stories: Examples from Peer-Reviewed PublicationsNicole Coustier
Published on: 25/02/2025

Learn how payer claims data strengthens medtech value stories without long clinical trials.

Evidence Planning
Real-World Data vs. Traditional Studies: What MedTech Innovators Need to Know

Real-World Data vs. Traditional Studies: What MedTech Innovators Need to Know

Real-World Data vs. Traditional Studies: What MedTech Innovators Need to KnowNicole Coustier
Published on: 25/01/2025

Understand how real-world data strengthens your U.S. reimbursement case beyond traditional trials.

Evidence Planning
Comparative Effectiveness for AI MedTech

Comparative Effectiveness for AI MedTech

Comparative Effectiveness for AI MedTechNicole Coustier
Published on: 04/09/2024

Why comparing your AI MedTech solution to the status quo isn’t enough for payer approval.

Evidence Planning
FDA vs. CMS Mandates for Evaluating Novel MedTech

FDA vs. CMS Mandates for Evaluating Novel MedTech

FDA vs. CMS Mandates for Evaluating Novel MedTechNicole Coustier
Published on: 31/05/2024

FDA approval ensures safety and effectiveness—but CMS needs proof of clinical value. Here’s how to align your strategy with both mandates.

Evidence Planning